Immunotherapy and chemotherapy — a practical partnership (original) (raw)

• Raff, M. C. Social controls on cell survival and cell death. Nature 356, 397–400 (1992).
  Article CAS Google Scholar
• Degterev, A., Boyce, M. & Yuan, J. A decade of caspases. Oncogene 22, 8543–8567 (2003).
  Article CAS Google Scholar
• Savill, J. & Fadok, V. Corpse clearance defines the meaning of cell death. Nature 407, 784–788 (2000).
  CAS Google Scholar
• Kerr, J. F., Wyllie, A. H. & Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239–257 (1972).
  Article CAS Google Scholar
• Restifo, N. P. Building better vaccines: how apoptotic cell death can induce inflammation and activate innate and adaptive immunity. Curr. Opin. Immunol. 12, 597–603 (2000).
  Article CAS Google Scholar
• Sotomayor, E. M. et al. Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression. Blood 98, 1070–1077 (2001).
  Article CAS Google Scholar
• Cuenca, A. et al. Extra-lymphatic solid tumor growth is not immunologically ignored and results in early induction of antigen-specific T-cell anergy: dominant role of cross-tolerance to tumor antigens. Cancer Res. 63, 9007–9015 (2003).
  CAS PubMed Google Scholar
• Ozoren, N. & El-Deiry, W. S. Cell surface Death Receptor signaling in normal and cancer cells. Semin. Cancer Biol. 13, 135–147 (2003).
  Article Google Scholar
• Mesner, P. W. Jr, Budihardjo, II & Kaufmann, S. H. Chemotherapy-induced apoptosis. Adv. Pharmacol. 41, 461–499 (1997).
  Article CAS Google Scholar
• Kaufmann, S. H. & Earnshaw, W. C. Induction of apoptosis by cancer chemotherapy. Exp. Cell Res. 256, 42–49 (2000).
  Article CAS Google Scholar
• Li, X. et al. Apoptotic cell death during treatment of leukemias. Leuk. Lymphoma 13 (Suppl. 1), 65–70 (1994).
  Article Google Scholar
• Kim, R., Nishimoto, N., Inoue, H., Yoshida, K. & Toge, T. An analysis of the therapeutic efficacy of protracted infusion of low-dose 5-fluorouracil and cisplatin in advanced gastric cancer. J. Infect. Chemother. 6, 222–228 (2000).
  Article CAS Google Scholar
• Cassinelli, G. et al. A role for loss of p53 function in sensitivity of ovarian carcinoma cells to taxanes. Int. J. Cancer 92, 738–747 (2001).
  Article CAS Google Scholar
• Salomons, G. S. et al. Bcl-2 family members in childhood acute lymphoblastic leukemia: relationships with features at presentation, in vitro and in vivo drug response and long-term clinical outcome. Leukemia 13, 1574–1580 (1999).
  Article CAS Google Scholar
• Okada, H. & Mak, T. W. Pathways of apoptotic and non-apoptotic death in tumour cells. Nature Rev. Cancer 4, 592–603 (2004).
  Article CAS Google Scholar
• Edinger, A. L. & Thompson, C. B. Death by design: apoptosis, necrosis and autophagy. Curr. Opin. Cell Biol. 16, 663–669 (2004).
  Article CAS Google Scholar
• Levine, B. & Klionsky, D. J. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev. Cell 6, 463–477 (2004).
  Article CAS Google Scholar
• Kanzawa, T. et al. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ. 11, 448–457 (2004).
  Article CAS Google Scholar
• Pagani, E. et al. DNA repair enzymes and cytotoxic effects of temozolomide: comparative studies between tumor cells and normal cells of the immune system. J. Chemother. 15, 173–183 (2003).
  Article CAS Google Scholar
• De Vleeschouwer, S. et al. Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report. J. Neurosurg. Spine 100, 492–497 (2004).
  Google Scholar
• Jordan, M. A. et al. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res. 56, 816–825 (1996).
  CAS PubMed Google Scholar
• Russell, P. & Nurse, P. cdc25+ functions as an inducer in the mitotic control of fission yeast. Cell 45, 145–153 (1986).
  Article CAS Google Scholar
• Eralp, Y. et al. Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model. Breast Cancer Res. 6, R275–R283 (2004).
  Article CAS Google Scholar
• Bonnotte, B. et al. Bcl-2-mediated inhibition of apoptosis prevents immunogenicity and restores tumorigenicity of spontaneously regressive tumors. J. Immunol. 161, 1433–1438 (1998).
  CAS PubMed Google Scholar
• Leitner, W. W. et al. Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines. Vaccine 22, 1537–1544 (2004).
  Article CAS Google Scholar
• Sasaki, S., Amara, R. R., Oran, A. E., Smith, J. M. & Robinson, H. L. Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases. Nature Biotechnol. 19, 543–547 (2001).
  Article CAS Google Scholar
• Chattergoon, M. A. et al. Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis. Nature Biotechnol. 18, 974–979 (2000).
  Article CAS Google Scholar
• Steinman, R. M., Turley, S., Mellman, I. & Inaba, K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191, 411–416 (2000).
  Article CAS Google Scholar
• Kim, S., Elkon, K. B. & Ma, X. Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells. Immunity 21, 643–653 (2004).
  Article CAS Google Scholar
• Rovere, P. et al. Delayed clearance of apoptotic lymphoma cells allows cross-presentation of intracellular antigens by mature dendritic cells. J. Leukoc. Biol. 66, 345–349 (1999).
  Article CAS Google Scholar
• Feng, H., Zeng, Y., Graner, M. W. & Katsanis, E. Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells. Blood 100, 4108–4115 (2002).
  Article CAS Google Scholar
• Golpon, H. A. et al. Life after corpse engulfment: phagocytosis of apoptotic cells leads to VEGF secretion and cell growth. FASEB J. 18, 1716–1718 (2004).
  Article CAS Google Scholar
• Shi, Y., Evans, J. E. & Rock, K. L. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425, 516–521 (2003).
  Article CAS Google Scholar
• Sauter, B. et al. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191, 423–434 (2000).
  Article CAS Google Scholar
• Skoberne, M., Beignon, A. S. & Bhardwaj, N. Danger signals: a time and space continuum. Trends Mol. Med. 10, 251–257 (2004).
  Article CAS Google Scholar
• Robbins, P. in Tumor immunology: molecularly defined antigens and clinical applications (eds Parmiani, G. & Lotze, M.) 11 (Harwood Academic Publishers, London, 2002).
  Google Scholar
• Novellino, L., Castelli, C. & Parmiani, G. A listing of human tumor antigens recognized by T cells: March 2004 update. Cancer Immunol. Immunother. 54, 187–207 (2005).
  Article CAS Google Scholar
• Kawakami, Y. & Rosenberg, S. A. Human tumor antigens recognized by T-cells. Immunol. Res. 16, 313–339 (1997).
  Article CAS Google Scholar
• Marzo, A. L., Lake, R. A., Robinson, B. W. S. & Scott, B. T cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors. Cancer Res. 59, 1071–1079 (1999).
  CAS PubMed Google Scholar
• Stumbles, P. A. et al. Cutting Edge: Tumor-specific CTL are constitutively cross-armed in draining lymph nodes and transiently disseminate to mediate tumor regression following systemic CD40 activation. J. Immunol. 173, 5923–5928 (2004).
  Article CAS Google Scholar
• Nowak, A. K. et al. Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells. J. Immunol. 170, 4905–4913 (2003).
  Article CAS Google Scholar
• Nelson, D., Bundell, C. & Robinson, B. In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes. J. Immunol. 165, 6123–6132 (2000).
  Article CAS Google Scholar
• Nowak, A. K., Robinson, B. W. & Lake, R. A. Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapy. Cancer Res. 62, 2353–2358 (2002).
  CAS PubMed Google Scholar
• Polak, L. & Turk, J. L. Reversal of immunological tolerance by cyclophosphamide through inhibition of suppressor cell activity. Nature 249, 654–656 (1974).
  Article CAS Google Scholar
• Fehervari, Z. & Sakaguchi, S. Development and function of CD25+CD4+ regulatory T cells. Curr. Opin. Immunol. 16, 203–208 (2004).
  Article CAS Google Scholar
• Ghiringhelli, F. et al. CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative. Eur. J. Immunol. 34, 336–344 (2004).
  Article CAS Google Scholar
• Heath, W. R. & Carbone, F. R. Cross-presentation in viral immunity and self-tolerance. Nature Rev. Immunol. 1, 126–134 (2001).
  Article CAS Google Scholar
• Morgan, D. J., Kreuwel, H. T. & Sherman, L. A. Antigen concentration and precursor frequency determine the rate of CD8+ T cell tolerance to peripherally expressed antigens. J. Immunol. 163, 723–727 (1999).
  CAS PubMed Google Scholar
• Miller, J. F. & Morahan, G. Peripheral T cell tolerance. Annu. Rev. Immunol. 10, 51–69 (1992).
  Article CAS Google Scholar
• Nowak, A. K., Robinson, B. W. & Lake, R. A. Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors. Cancer Res. 63, 4490–4496 (2003).
  CAS PubMed Google Scholar
• Srivastava, P. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu. Rev. Immunol. 20, 395–425 (2002).
  Article CAS Google Scholar
• Fadok, V. A., Bratton, D. L., Guthrie, L. & Henson, P. M. Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: role of proteases. J. Immunol. 166, 6847–6854 (2001).
  Article CAS Google Scholar
• Rad, A. N. et al. The differential influence of allogeneic tumor cell death via DNA damage on dendritic cell maturation and antigen presentation. Cancer Res. 63, 5143–5150 (2003).
  CAS PubMed Google Scholar
• Friesen, C., Herr, I., Krammer, P. H. & Debatin, K. M. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nature Med. 2, 574–577 (1996).
  Article CAS Google Scholar
• Bergmann-Leitner, E. S. & Abrams, S. I. Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8+ cytotoxic T lymphocytes. Cancer Immunol. Immunother. 50, 445–455 (2001).
  Article CAS Google Scholar
• Yang, S. & Haluska, F. G. Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways. J. Immunol. 172, 4599–4608 (2004).
  Article CAS Google Scholar
• Kaech, S. M. et al. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nature Immunol. 4, 1191–1198 (2003).
  Article CAS Google Scholar
• Wherry, E. J., Barber, D. L., Kaech, S. M., Blattman, J. N. & Ahmed, R. Antigen-independent memory CD8 T cells do not develop during chronic viral infection. Proc. Natl Acad. Sci. USA 101, 16004–16009 (2004).
  Article CAS Google Scholar
• Dudley, M. E. et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298, 850–854 (2002).
  Article CAS Google Scholar
• Burnet, F. M. Immunological recognition of self. Science 133, 307–311 (1961).
  Article CAS Google Scholar
• Mason, D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today 19, 395–404 (1998).
  Article CAS Google Scholar
• Matzinger, P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12, 991–1045 (1994).
  Article CAS Google Scholar
• Janeway, C. A. Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today 13, 11–16 (1992).
  Article CAS Google Scholar
• Medzhitov, R. & Janeway, C. Jr., Innate immune recognition: mechanisms and pathways. Immunol. Rev. 173, 89–97 (2000).
  Article CAS Google Scholar
• Medzhitov, R. & Janeway, C. A. Jr. Decoding the patterns of self and nonself by the innate immune system. Science 296, 298–300 (2002).
  Article CAS Google Scholar
• Lyons, A. B. & Parish, C. R. Determination of lymphocyte division by flow cytometry. J. Immunol. Methods 171, 131–137 (1994).
  Article CAS Google Scholar
• Oehen, S. & Brduscha-Riem, K. Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. J. Immunol. 161, 5338–5346 (1998).
  CAS PubMed Google Scholar
• Davis, M. M. et al. Ligand recognition by αβ T cell receptors. Annu. Rev. Immunol. 16, 523–544 (1998).
  Article CAS Google Scholar
• Miyahira, Y. et al. Quantification of antigen specific CD8+ T cells using an ELISPOT assay. J. Immunol. Methods 181, 45–54 (1995).
  Article CAS Google Scholar
• North, R. J. & Kirstein, D. P. T-cell–mediated concomitant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasites. J. Exp. Med. 145, 275–292 (1977).
  Article CAS Google Scholar